1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic SyndromeHemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndromeActive, not recruitingPhase 32026-05-06NCT04401748